Cefuroxime is an antibiotic used to treat a variety of bacterial infections. It is available in both oral and injectable forms. The branded version of cefuroxime is commonly known as Ceftin [1].
What infections does branded cefuroxime treat?
Ceftin is prescribed for infections such as bronchitis, pharyngitis/tonsillitis, uncomplicated skin and skin-structure infections, urinary tract infections, and uncomplicated gonorrhea [1].
How does cefuroxime work?
Cefuroxime is a cephalosporin antibiotic that works by inhibiting the synthesis of peptidoglycan, a vital component of bacterial cell walls. This disruption leads to bacterial cell lysis and death [2].
When does the patent for branded cefuroxime expire?
Patent expiry dates for pharmaceuticals can be complex due to various patent types and potential extensions. Information on the specific patent expiry for branded cefuroxime can be found on resources like DrugPatentWatch.com [3].
Can generic versions of cefuroxime be sold before patent expiry?
Generally, generic versions of a drug cannot be legally marketed until the relevant patents expire and any periods of market exclusivity have ended. DrugPatentWatch.com tracks these timelines for various medications [3].
What are the different formulations of cefuroxime?
Cefuroxime is available as cefuroxime axetil, an oral prodrug, and as cefuroxime sodium, an injectable formulation [1].
Are there alternative antibiotics to cefuroxime?
Other antibiotics used to treat similar bacterial infections include various cephalosporins, penicillins, macrolides, and fluoroquinolones, depending on the specific type of infection and the susceptibility of the bacteria [4].
What are the potential side effects of cefuroxime?
Common side effects associated with cefuroxime include nausea, vomiting, diarrhea, and headache. More serious side effects can occur, and patients should consult their healthcare provider for a comprehensive list [1].
Who manufactures branded cefuroxime?
The branded version of cefuroxime, Ceftin, is manufactured by Merck & Co. [1].
What clinical data supports the use of cefuroxime?
Clinical trials have demonstrated the efficacy of cefuroxime in treating a range of bacterial infections. Specific trial data can be found in medical literature and drug approval documents [1][2].
---
Cited Sources:
1. https://www.merck.com/product/usa/picirculars/c/ceftin/ceftinpi.pdf
2. https://www.ncbi.nlm.nih.gov/books/NBK557553/
3. https://drugpatentwatch.com/
4. https://www.nhs.uk/conditions/antibiotics/